Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares CANF

$1.51 -1.31% at last close

Recent SEC Filings

FormDescriptionFiledDocument
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-11-18 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-11-12 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-11-09 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-11-02 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-10-26 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-09-09 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-09-08 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-09-03 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-09-02 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-09-02 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-08-17 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-08-12 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-08-03 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-07-20 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-07-14 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-07-06 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-07-01 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-06-26 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-06-22 View →
6-K FORM 6-K 2026-06-17 View →
4 Insider transaction 2026-06-08 View →
4 Insider transaction 2026-06-08 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-06-04 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-06-02 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-05-28 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-05-18 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-05-13 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-04-30 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-04-23 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-03-30 View →
20-F ANNUAL REPORT 2026-03-26 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-03-26 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-03-17 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-03-10 View →
6-K CURRENT REPORT 2026-03-05 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-03-04 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-03-03 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-02-17 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-02-09 View →
6-K REPORT OF FOREIGN PRIVATE ISSUER 2026-02-05 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$1.51
Market Cap
$4.64 million
52-Week Range
$1.42 – $12.30
Average Volume
59K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.